ChiCTR2200056545Not yet recruiting
Untitled Trial
A randomized controlled clinical study of hyperthermic intraperitoneal chemotherapy (HIPEC) combined with intraperitoneal infusion chemotherapy for gastric cancer with peritoneal metastasis
Liaoning Cancer Hospital & Institute/Cancer Hospital of Daliian University of TechnologyPhase 2Chinese Clinical Trial Registry
Study focus
- Disease/Condition
- gastric cancer
Sponsor & location
- Primary sponsor
- Liaoning Cancer Hospital & Institute/Cancer Hospital of Daliian University of Technology
- Funder
- No
- Location
- China
Timeline & enrollment
- Phase
- Phase 2
- Start date
- N/A
- End date
- Jul 31, 2024
ICD-10 classifications
Gastric ulcerMalignant neoplasm of stomachMalignant neoplasm: Body of stomachCarcinoma in situ: StomachMalignant neoplasm: Stomach, unspecified
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2200056545
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2200056545 through Pure Global AI's free database. This Phase 2 trial is sponsored by Liaoning Cancer Hospital & Institute/Cancer Hospital of Daliian University of Technology and is currently Not yet recruiting. The study focuses on gastric cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.